MyMD Pharmaceuticals Inc (MYMD)

NASDAQ
2.100
-0.180(-7.89%)
  • Volume:
    32,828
  • Day's Range:
    2.100 - 2.380
  • 52 wk Range:
    1.880 - 9.950

MYMD Overview

Prev. Close
2.28
Day's Range
2.1-2.38
Revenue
-
Open
2.27
52 wk Range
1.88-9.95
EPS
-0.84
Volume
32,828
Market Cap
79.92M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
66,270
P/E Ratio
-
Beta
0.87
1-Year Change
-65.57%
Shares Outstanding
38,058,245
Next Earnings Date
Aug 17, 2022
What is your sentiment on MyMD Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

MyMD Pharmaceuticals Inc News

MyMD Pharmaceuticals Inc Analysis

MyMD Pharmaceuticals Inc Company Profile

MyMD Pharmaceuticals Inc Company Profile

Employees
9

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical-stage small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. MYMD-1 is being developed to treat age-related illnesses, such as frailty and sarcopenia. MYMD-1 works by regulating the release of numerous pro-inflammatory cytokines, such as TNF-a, interleukin 6 (IL-6) and interleukin 17 (IL-17). Supera-CBD is a synthetic analog of cannabidiol (CBD) being developed to treat various conditions, including epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid receptors and monoamine oxidase enzyme (MAO) type B. Supera-CBD is also used in treating neuroinflammatory and neurodegenerative diseases.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • Merger
    0
    • https://www.businesswire.com/news/home/20201202005600/en/Akers%E2%80%99-Proposed-Merger-Partner-MyMD-Pharmaceuticals-Announces-Issuance-of-Key-Patent
      0
      • Very interesting. Thank you
        0
      • As well as informative.
        0
    • This stock needs more volume that's all.
      0
      • This stock needs more volume that's all.
        0
        • Any news?
          0
          • yok,ibneler share sayisini kisitlamislar
            0
        • pre market..
          0
          • +612%...
            0
            • what a day! still holding my bag until .60+
              0
              • looks like you lost your bag
                0
              • In which Platform you are trade this one. I can't found it on MT5
                0
            • the next is 0.60
              0
              • reverse splitting is a new method by which Americans steal money from investors
                0